Ettenger R B, Robinson B J, Uittenbogaart C H, Hacker T A, Pennisi A J, Malekzadeh M H, Fine R N
Transplant Proc. 1979 Mar;11(1):401-3.
A positive CDC B-lymphocyte XM is not deleterious to long-term graft outcome. A positive unfractionated CDC XM is not a contraindication to transplantation if the positive crossmatch is due entirely to anti-B-lymphocyte antibody. B-lymphocyte autoantibodies are common in hemodialysis patients, but may account for only a minority of positive B-lymphocyte XMs.